Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors
暂无分享,去创建一个
[1] J. Grande,et al. Serum Insulin-like Growth Factor-I and Mammary Tumor Development in Ad libitum–Fed, Chronic Calorie–Restricted, and Intermittent Calorie–Restricted MMTV-TGF-α Mice , 2009, Cancer Prevention Research.
[2] C. Pirker,et al. Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells , 2009, Molecular Cancer Therapeutics.
[3] Weiqin Jiang,et al. Effects of Physical Activity and Restricted Energy Intake on Chemically Induced Mammary Carcinogenesis , 2009, Cancer Prevention Research.
[4] S. Woods,et al. The Role of Hypothalamic Mammalian Target of Rapamycin Complex 1 Signaling in Diet-Induced Obesity , 2008, The Journal of Neuroscience.
[5] Weiqin Jiang,et al. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. , 2008, Cancer research.
[6] S. Strom,et al. Dietary Energy Balance Modulates Signaling through the Akt/Mammalian Target of Rapamycin Pathways in Multiple Epithelial Tissues , 2008, Cancer Prevention Research.
[7] J. Grande,et al. Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-α mice , 2007, Breast Cancer Research.
[8] J. Grande,et al. Prevention of Mammary Tumorigenesis by Intermittent Caloric Restriction: Does Caloric Intake During Refeeding Modulate the Response? , 2007, Experimental biology and medicine.
[9] Johan Hartman,et al. Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts , 2006 .
[10] Ji Luo,et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.
[11] B. Kahn,et al. Diet-induced Obesity Alters AMP Kinase Activity in Hypothalamus and Skeletal Muscle* , 2006, Journal of Biological Chemistry.
[12] L. Cantley,et al. Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.
[13] George Thomas,et al. Hypothalamic mTOR Signaling Regulates Food Intake , 2006, Science.
[14] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[15] A. Marette,et al. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. , 2005, Endocrinology.
[16] J. Lindsley,et al. Nutrient sensing and metabolic decisions. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[17] R. Weindruch,et al. Metabolic adaptations to fasting and chronic caloric restriction in heart, muscle, and liver do not include changes in AMPK activity. , 2004, American journal of physiology. Endocrinology and metabolism.
[18] Dihua Yu,et al. Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers , 2004, Clinical Cancer Research.
[19] Weiqin Jiang,et al. Effect of Dietary Energy Restriction on Vascular Density during Mammary Carcinogenesis , 2004, Cancer Research.
[20] J. Grande,et al. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-α mice , 2004, International Journal of Obesity.
[21] M. Birnbaum,et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.
[22] F. Berrino,et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. , 2004, European journal of endocrinology.
[23] D. Berrigan,et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. , 2003, Annual review of medicine.
[24] L. Cantley,et al. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.
[25] P. A. van den Brandt,et al. Energy restriction and the risk of spontaneous mammary tumors in mice: A meta‐analysis , 2003, International journal of cancer.
[26] M. Mita,et al. Mammalian target of rapamycin: a new molecular target for breast cancer. , 2003, Clinical breast cancer.
[27] M. Mita,et al. The Molecular Target of Rapamycin (mTOR) as a Therapeutic Target Against Cancer , 2003, Cancer biology & therapy.
[28] N. Maihle,et al. Effect of Moderate Caloric Restriction and/or Weight Cycling on Mammary Tumor Incidence and Latency in MMTV-Neu Female Mice , 2002, Nutrition and cancer.
[29] Weiqin Jiang,et al. An experimental paradigm for studying the cellular and molecular mechanisms of cancer inhibition by energy restriction , 2002, Molecular carcinogenesis.
[30] J. Grande,et al. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[31] Shile Huang,et al. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. , 2002, Current opinion in investigational drugs.
[32] N. Sonenberg,et al. Cell-cycle-dependent translational control. , 2001, Current opinion in genetics & development.
[33] Tobias Schmelzle,et al. TOR, a Central Controller of Cell Growth , 2000, Cell.
[34] Zongjian Zhu,et al. Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. , 1997, Carcinogenesis.
[35] M. Merino,et al. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues , 1996, International journal of cancer.
[36] P. G. Reeves,et al. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.
[37] T. Powles,et al. The prognostic significance of transforming growth factors in human breast cancer. , 1993, British Journal of Cancer.
[38] J. Lundy,et al. Expression of neu protein, epidermal growth factor receptor, and transforming growth factor alpha in breast cancer. Correlation with clinicopathologic parameters. , 1991, The American journal of pathology.
[39] B. Hogan,et al. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice , 1990, Cell.
[40] R. Shao,et al. Dietary Manipulation of Mammary Tumor Development in Adult C3H/Bi Mice , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[41] N. Day,et al. Calorie Consumption Level Influences Development of C3H/Ou Breast Adenocarcinoma with Indifference to Calorie Source , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[42] M. Tucker. The effect of long‐term food restriction on tumours in rodents , 1979, International journal of cancer.
[43] A. J. Carlson,et al. Apparent prolongation of the life span of rats by intermittent fasting. , 1946, The Journal of nutrition.
[44] J. Grande,et al. Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages. , 2010, Oncology letters.
[45] Johan Hartman,et al. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. , 2006, Cancer research.
[46] D. Carling,et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.
[47] R. Kaaks. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. , 2004, Novartis Foundation symposium.
[48] J. Grande,et al. Effect of high fat diet on body weight and mammary tumor latency in MMTV-TGF-alpha mice. , 2004, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[49] W. Gullick,et al. The type I growth factor receptors in human breast cancer , 2004, Breast Cancer Research and Treatment.
[50] M. Carlson,et al. Supplemental Data LKB 1 Is the Upstream Kinase in the AMP-Activated Protein Kinase Cascade , 2003 .
[51] S. Hankinson,et al. Insulin-like growth factor and breast cancer risk: evidence from observational studies. , 2003, Breast disease.
[52] D. Hardie,et al. The AMP-activated protein kinase--fuel gauge of the mammalian cell? , 1997, European journal of biochemistry.
[53] B. Hogan,et al. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. , 1990, Cell.
[54] M. Pariza. Fat, calories, and mammary carcinogenesis: net energy effects. , 1987, The American journal of clinical nutrition.